Venture Capital and how to find, approach and work with VC firms

Shane Johnson of Hamilton BioVentures will be on the investor panel that will help evaluate the company pitches at the 23rd Annual Investors Choice® Venture Capital Conference in Salt Lake City.

Dr. Shane Johnson, Principal, has over 8 years of experience in biotechnology strategy consulting and management. He served as a Consultant to Hamilton BioVentures I, helping to evaluate a number of investment opportunities including the fund’s investments in Ceregene and TransOral Pharmaceuticals. Prior to joining Hamilton II, Dr. Johnson worked as an Engagement Manager in the Life Science Practice at L.E.K. Consulting, an international strategy consulting firm.

Prior to consulting, Dr. Johnson was the Director of Strategic Planning at Bionomix (now Eidogen-Sertanty), a computational chemistry and bioinformatics company, and before that he held the same title at Arbor Vita Corporation, a development-stage immune therapeutics company.

Dr. Johnson is on the Board of Directors of Fritsche Capital Group, a private and independent investment bank, where he also serves as Chairman of the Life Science Practice.

With an active interest in international health, Dr. Johnson has done considerable volunteer work in areas such as Latin America and Papua New Guinea. Dr. Johnson received a B.A. in Studio Art and a B.S. in Neuroscience (with honors) from Brown University, and was awarded an M.D. from the Stanford University School of Medicine. He is also a Fulbright Scholar.